⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
STARHEALTH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.8
| Stock Code | STARHEALTH | Market Cap | 27,725 Cr. | Current Price | 472 ₹ | High / Low | 534 ₹ |
| Stock P/E | 62.1 | Book Value | 0.00 ₹ | Dividend Yield | 0.00 % | ROCE | 12.0 % |
| ROE | 9.37 % | Face Value | 10.0 ₹ | DMA 50 | 456 ₹ | DMA 200 | 458 ₹ |
| Chg in FII Hold | 0.56 % | Chg in DII Hold | -0.13 % | PAT Qtr | 128 Cr. | PAT Prev Qtr | 54.9 Cr. |
| RSI | 63.7 | MACD | -1.48 | Volume | 6,09,478 | Avg Vol 1Wk | 16,44,658 |
| Low price | 327 ₹ | High price | 534 ₹ | PEG Ratio | 1.65 | 52w Index | 69.8 % |
| Qtr Profit Var | -40.4 % | EPS | 7.59 ₹ | Industry PE | 33.2 |
📊 Technical Analysis
- Chart Patterns: Stock is trading slightly above both 50 DMA (456 ₹) and 200 DMA (458 ₹), showing consolidation with mild bullish bias.
- Moving Averages: Current price (472 ₹) above both averages → supportive of short-term bullish momentum.
- RSI: 63.7 → approaching overbought zone, suggesting caution for further upside.
- MACD: -1.48 → mild bearish crossover, indicating short-term weakness despite overall uptrend.
- Bollinger Bands: Price near upper band, showing strong momentum but risk of pullback.
- Volume Trends: Current volume (6.09 lakh) well below 1-week average (16.4 lakh), showing reduced participation.
📈 Momentum & Signals
- Short-term Momentum: Neutral to bullish, supported by price above DMA but capped by RSI nearing overbought.
- Entry Zone: 460–470 ₹ (near DMA support).
- Exit Zone: 490–500 ₹ (near resistance zone).
- Trend Status: Consolidating with bullish tilt; reversal possible only if price sustains above 490 ₹.
✅ Positive
- PAT improved sequentially (54.9 Cr. → 128 Cr.).
- EPS of 7.59 ₹ reflects earnings growth.
- FII holdings increased by 0.56%, showing foreign investor confidence.
- 52-week index performance at 69.8% highlights strong relative strength.
⚠️ Limitation
- High P/E of 62.1 compared to industry PE of 33.2.
- Dividend yield of 0.00% limits income appeal.
- Book value not available, reducing valuation clarity.
- Volume participation lower than average, indicating cautious trading activity.
📉 Company Negative News
- Quarterly profit variation shows decline (-40.4%).
- DII holdings decreased by -0.13%, showing reduced domestic institutional confidence.
📈 Company Positive News
- Sequential PAT growth (+133%) shows strong earnings recovery.
- FII inflows indicate renewed foreign interest.
🏭 Industry
- Industry PE at 33.2, much lower than STARHEALTH’s 62.1, suggesting sector peers may be more attractively valued.
- Insurance sector remains growth-oriented with rising demand for health coverage.
🔎 Conclusion
- STARHEALTH is consolidating near support levels with mixed signals: bullish DMA setup but weak MACD and high RSI.
- Short-term traders may consider entry around 460–470 ₹ with exit near 490–500 ₹.
- Long-term investors should be cautious due to high valuation and modest efficiency metrics despite strong sequential earnings recovery.